end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccruedLiabilitiesCurrent,AccruedProfessionalFeesCurrent,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllocatedShareBasedCompensationExpense,AmortizationOfFinancingCosts,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,Depreciation,EarningsPerShareBasicAndDiluted,EmployeeRelatedLiabilitiesCurrent,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,FairValueOfAssetsAcquired,GeneralAndAdministrativeExpense,IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InterestIncomeExpenseNet,LeaseCost,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LoansPayableToBankCurrent,NetCashProvidedByUsedInContinuingOperations,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseCost,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeasePayments,OperatingLeaseRightOfUseAsset,OperatingLeaseRightOfUseAssetAmortizationExpense,OperatingLeaseWeightedAverageDiscountRatePercent,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock,ProceedsFromIssuanceOfRedeemablePreferredStock,ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions,ProceedsFromStockOptionsExercised,PropertyPlantAndEquipmentNet,RepaymentsOfBankDebt,ResearchAndDevelopmentExpense,RestrictedCashNoncurrent,RetainedEarningsAccumulatedDeficit,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1,StockholdersEquity,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueStockOptionsExercised,VariableLeaseCost,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,AccumulatedOtherComprehensiveIncomeLossNetOfTax,ComprehensiveIncomeNetOfTax,LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive,LesseeOperatingLeaseLiabilityPaymentsDueYearFive,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LongTermInvestments,OperatingLeasesRentExpenseMinimumRentals,OtherComprehensiveIncomeLossNetOfTax,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax,PaymentsToAcquireAvailableForSaleSecurities,PreferredStockValue,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2020-12-31,2021-03-29,10-K,"Silverback Therapeutics, Inc.",SBTX,CIK0001671858,USD,2583000.0,5278000.0,581000.0,479608000.0,,,,,394804000.0,390656000.0,386569000.0,386919000.0,7928031.0,0.0001,200000000.0,34801537.0,34701274.0,3000.0,,,2634000.0,,,,,,,,,,,,11927000.0,394804000.0,9601000.0,844000.0,,,,,,,,,,896000.0,2326000.0,,2180000.0,,,,0.0001,10000000.0,0.0,0.0,4087000.0,,,,,1618000.0,,,350000.0,-96734000.0,,,,,,,,,,223647000.0,6316569.0,10.93,,,,,,,382877000.0,,,,,0.0,,,,,,0.0,,,,,0.0,
2021-03-31,2021-05-13,10-Q,"Silverback Therapeutics, Inc.",SBTX,CIK0001671858,USD,4374000.0,5799000.0,523000.0,484147000.0,4285000.0,4285000.0,1000.0,6404001.0,382199000.0,378346000.0,374205000.0,374555000.0,9556911.0,0.0001,200000000.0,34903497.0,34827204.0,3000.0,186000.0,-0.54,1666000.0,59600000.0,136000.0,6646000.0,2208000.0,54000.0,18000.0,453000.0,3278000.0,824000.0,2454000.0,297000.0,13650000.0,382199000.0,11595000.0,495000.0,-12364000.0,-128000.0,-35000.0,-12201000.0,-18867000.0,18885000.0,-18885000.0,347000.0,2981000.0,927000.0,2055000.0,421000.0,1900000.0,280000.0,0.085,35000.0,0.0001,10000000.0,0.0,0.0,4141000.0,,,,222000.0,1603000.0,350000.0,12239000.0,350000.0,-115601000.0,4285000.0,,0.0,0.83,0.0072,9564798.0,4227000.0,93973.0,33.32,202325000.0,6308582.0,11.63,25956000.0,708833.0,6.97,2.18,48.03,3600000.0,368549000.0,101960.0,254000.0,106000.0,34773950.0,,,,,,,,,-18867000.0,,,,
2021-06-30,2021-08-12,10-Q,"Silverback Therapeutics, Inc.",SBTX,CIK0001671858,USD,1805000.0,12785000.0,945000.0,489743000.0,4730000.0,4730000.0,,,366976000.0,363027000.0,359689000.0,360039000.0,9433408.0,0.0001,200000000.0,34998372.0,34963085.0,4000.0,,-0.7,2175000.0,60400000.0,,6762000.0,,,15000.0,453000.0,2971000.0,517000.0,2454000.0,235000.0,17326000.0,366976000.0,15548000.0,0.0,,,,,-24496000.0,24511000.0,-24511000.0,347000.0,2736000.0,958000.0,1778000.0,413000.0,1615000.0,,0.085,,0.0001,10000000.0,0.0,0.0,3338000.0,,,,,1984000.0,,17749000.0,350000.0,-140097000.0,,,,,,9564798.0,,,,121425000.0,6467507.0,12.56,26546000.0,1156286.0,8.0,,,,349650000.0,,,106000.0,34876050.0,,,,,,,,,-24496000.0,,,,
2021-09-30,2021-11-10,10-Q,"Silverback Therapeutics, Inc.",SBTX,CIK0001671858,USD,1720000.0,12537000.0,620000.0,494916000.0,5019000.0,5019000.0,,,352561000.0,305355000.0,300660000.0,301010000.0,9382025.0,0.0001,200000000.0,35067751.0,35037136.0,4000.0,,-0.65,3279000.0,56700000.0,,7040000.0,,,26000.0,523000.0,7319000.0,268000.0,1615000.0,1149000.0,20427000.0,352561000.0,15347000.0,0.0,,,,,-22655000.0,22681000.0,-22681000.0,402000.0,6170000.0,1090000.0,5080000.0,499000.0,5011000.0,,0.075,,0.0001,10000000.0,0.0,0.0,4695000.0,,,,,1907000.0,,15641000.0,350000.0,-162752000.0,,,,,,9564798.0,,,,21707000.0,6451285.0,12.88,7670000.0,1549117.0,8.83,,,,332134000.0,,154000.0,121000.0,35001466.0,-34000.0,-22689000.0,1186000.0,1389000.0,1348000.0,1513000.0,39938000.0,,-22689000.0,-34000.0,,0.0,3100000.0
